Chemoinformaics analysis of 3-Hydroxy-2-pentanone
Molecular Weight | 102.133 | nRot | 2 |
Heavy Atom Molecular Weight | 92.053 | nRig | 3 |
Exact Molecular Weight | 102.068 | nRing | 0 |
Solubility: LogS | -5.103 | nHRing | 0 |
Solubility: LogP | 6.807 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 16.6219 |
nHD | 1 | BPOL | 10.9001 |
QED | 0.318 |
Synth | 2.431 |
Natural Product Likeliness | 1.051 |
NR-PPAR-gamma | 0.971 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.011 |
CACO-2 | -4.742 |
MDCK | 0.0000198 |
BBB | 0.208 |
PPB | 0.982436 |
VDSS | 0.615 |
FU | 0.0164057 |
CYP1A2-inh | 0.243 |
CYP1A2-sub | 0.165 |
CYP2c19-inh | 0.11 |
CYP2c19-sub | 0.067 |
CYP2c9-inh | 0.432 |
CYP2c9-sub | 0.987 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.077 |
CYP3a4-inh | 0.078 |
CYP3a4-sub | 0.018 |
CL | 3.553 |
T12 | 0.578 |
hERG | 0.011 |
Ames | 0.004 |
ROA | 0.008 |
SkinSen | 0.961 |
Carcinogencity | 0.156 |
EI | 0.985 |
Respiratory | 0.248 |
NR-Aromatase | 0.349 |
Antiviral | No |
Prediction | 0.942276 |